Versor Investments LP decreased its stake in Veeva Methods Inc. (NYSE:VEEV – Free Report) by 41.5% through the third quarter, in response to its most up-to-date disclosure with the Securities & Alternate Fee. The fund owned 2,601 shares of the expertise firm’s inventory after promoting 1,848 shares through the quarter. Versor Investments LP’s holdings in Veeva Methods have been price $546,000 as of its most up-to-date SEC submitting.
A number of different hedge funds and different institutional buyers have additionally lately purchased and offered shares of the inventory. Mowery & Schoenfeld Wealth Administration LLC bought a brand new stake in Veeva Methods within the third quarter price roughly $26,000. Advisors Asset Administration Inc. acquired a brand new stake in Veeva Methods through the first quarter valued at $28,000. Blue Belief Inc. grew its place in Veeva Methods by 3,460.0% through the second quarter. Blue Belief Inc. now owns 178 shares of the expertise firm’s inventory valued at $33,000 after shopping for a further 173 shares through the interval. DT Funding Companions LLC bought a brand new place in Veeva Methods within the second quarter valued at $35,000. Lastly, Mather Group LLC. raised its place in shares of Veeva Methods by 166.3% within the second quarter. Mather Group LLC. now owns 253 shares of the expertise firm’s inventory price $46,000 after buying a further 158 shares through the interval. 88.20% of the inventory is owned by institutional buyers and hedge funds.
Veeva Methods Inventory Efficiency
Shares of Veeva Methods inventory opened at $233.37 on Thursday. The enterprise’s 50 day transferring common value is $214.81 and its 200 day transferring common value is $200.26. The corporate has a market cap of $37.79 billion, a price-to-earnings ratio of 62.23, a PEG ratio of two.28 and a beta of 0.81. Veeva Methods Inc. has a one 12 months low of $165.12 and a one 12 months excessive of $240.68.
Veeva Methods (NYSE:VEEV – Get Free Report) final introduced its quarterly earnings outcomes on Wednesday, August twenty eighth. The expertise firm reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.03. Veeva Methods had a web margin of 23.91% and a return on fairness of 13.30%. The agency had income of $676.18 million for the quarter, in comparison with analysts’ expectations of $667.21 million. On common, analysts predict that Veeva Methods Inc. will publish 4.21 EPS for the present fiscal 12 months.
Analyst Upgrades and Downgrades
A lot of equities analysis analysts have lately commented on the corporate. Barclays raised their goal value on Veeva Methods from $240.00 to $260.00 and gave the corporate an “chubby” score in a analysis report on Friday, November eighth. Financial institution of America raised their value goal on Veeva Methods from $204.00 to $240.00 and gave the corporate a “impartial” score in a report on Thursday, August twenty ninth. Royal Financial institution of Canada upped their goal value on Veeva Methods from $250.00 to $275.00 and gave the inventory an “outperform” score in a analysis be aware on Friday, November eighth. Guggenheim lifted their value goal on shares of Veeva Methods from $233.00 to $249.00 and gave the corporate a “purchase” score in a analysis be aware on Tuesday, October 1st. Lastly, Robert W. Baird decreased their value goal on shares of Veeva Methods from $251.00 to $245.00 and set an “outperform” score for the corporate in a analysis report on Monday, October twenty eighth. One funding analyst has rated the inventory with a promote score, seven have issued a maintain score and sixteen have assigned a purchase score to the inventory. Based mostly on information from MarketBeat, the corporate at the moment has a mean score of “Average Purchase” and a consensus goal value of $237.00.
Verify Out Our Newest Inventory Report on Veeva Methods
Insider Exercise
In different information, insider Thomas D. Schwenger offered 1,126 shares of Veeva Methods inventory in a transaction that occurred on Friday, November eighth. The shares have been offered at a mean value of $240.01, for a complete transaction of $270,251.26. Following the sale, the insider now owns 27,013 shares of the corporate’s inventory, valued at roughly $6,483,390.13. The commerce was a 0.00 % lower of their place. The transaction was disclosed in a submitting with the Securities & Alternate Fee, which may be accessed via this hyperlink. In different Veeva Methods information, SVP Jonathan Faddis offered 2,353 shares of the corporate’s inventory in a transaction dated Wednesday, August twenty first. The shares have been offered at a mean value of $200.00, for a complete worth of $470,600.00. Following the transaction, the senior vp now owns 9,035 shares of the corporate’s inventory, valued at $1,807,000. This represents a 0.00 % lower of their possession of the inventory. The transaction was disclosed in a submitting with the SEC, which is out there via this hyperlink. Additionally, insider Thomas D. Schwenger offered 1,126 shares of Veeva Methods inventory in a transaction dated Friday, November eighth. The shares have been offered at a mean value of $240.01, for a complete transaction of $270,251.26. Following the sale, the insider now owns 27,013 shares of the corporate’s inventory, valued at roughly $6,483,390.13. This represents a 0.00 % lower of their possession of the inventory. The disclosure for this sale may be discovered right here. Company insiders personal 10.50% of the corporate’s inventory.
Veeva Methods Profile
Veeva Methods Inc offers cloud-based software program for the life sciences business. It affords Veeva Industrial Cloud, a set of software program and analytics options, similar to Veeva buyer relationship administration (CRM) that allow customer-facing staff at pharmaceutical and biotechnology firms; Veeva Vault PromoMats, an end-to-end content material and digital asset administration resolution; Veeva Vault Medical that gives supply of medical content material throughout a number of channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical manufacturers; Veeva OpenData, a buyer reference information resolution; Veeva Hyperlink, an information software that permits hyperlink to generate real-time intelligence; and Veeva Compass consists of de-identified and longitudinal affected person information for the USA.
See Additionally
Need to see what different hedge funds are holding VEEV? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Veeva Methods Inc. (NYSE:VEEV – Free Report).
Obtain Information & Scores for Veeva Methods Every day – Enter your e mail deal with under to obtain a concise every day abstract of the newest information and analysts’ scores for Veeva Methods and associated firms with MarketBeat.com’s FREE every day e mail e-newsletter.
